At People for Law it is believed the ongoing hair relaxer lawsuit will evolve with fresh court rulings, procedural shifts, and new filings, shaping the path forward for thousands of affected individuals.
As 2025 comes to an end, the litigation landscape indeed remains dynamic, and for anyone following the case, staying updated is more critical than ever. Here is a detailed look at some of the latest court updates.
The Scope of the MDL & Explosion in Filings
Indeed, the mass litigation is always consolidated in a federal multidistrict litigation (MDL 3060), as overseen by Mary M. Rowland.
Around mid-2025, the number of pending claims surpassed 10,000, from uterine, ovarian, and endometrial cancer to other reproductive health issues, which are allegedly tied to the repeated use of the chemical hair relaxers. As the new hair relaxer lawsuit continues to be filed monthly, it reflects both the growing awareness and an expanding pool of potential plaintiffs.
Milestones of Bellwether Selection & Discovery
- Early 2025, the court initiated the bellwether case selection process, which aims to select a subset of cases that represent the broader litigation. However, both plaintiffs and defendants had to submit lists of potential bellwether cases by 30th April.
- Thus, by May, a group of 32 cases was indeed selected for fact discovery. Most of these cases involve allegations regarding uterine, ovarian, and endometrial cancer, which is tied to prolonged hair relaxer use.
- While the fact discovery phase involves exchanges of medical records, product histories, internal documents, and other key evidence, this is slated to continue even into early 2026. The court appointed Ellen K. Reisman as a special master to facilitate possible settlement talks. Thus, appointment of a special master is typical even in significant mass tort cases, which are designed to streamline the negotiations, but it never guarantees an immediate settlement.
Court Rulings, Procedural Moves & Evidentiary Phase
According to the experts at People for Law, in 2025, defendants’ motions to dismiss several participants’ claims were denied, preserving several claims.
The litigation remains active, and the court continues to manage scheduling, document exchange, and deposition timelines. Therefore, a critical development known as the “Science Day” is scheduled for January 8, 2026. On that specific day, experts from both sides will definitely present scientific evidence about whether chemical hair relaxers can cause and increase the risk of hormone-related cancers.
While the outcome and expert testimony certainly influence jury decisions or settlement negotiations down the line as well.
Settlement Talks & What Comes Next
The presence of a special master and growing case volume definitely raises the possibility of broader settlement discussions, though nothing is locked in yet. If the bellwether trials return plaintiff-favorable verdicts or if defendants conclude that a settlement is more feasible than multiple trials, negotiations certainly intensify, potentially bringing compensation to several claimants sooner than expected.
As of now, global settlements or payouts have indeed been publicly confirmed. The litigation remains in pre-trial phases, with the first jury trials anticipated around 2027, after discovery, expert testimony, and pre-trial motions are completed.
What This Means for Plaintiffs
If you or someone you might know used chemical hair relaxers and later developed uterine, ovarian, and endometrial cancer or other hormone-related conditions, now is the time to act. Definitely document your product use and history, save medical records, and always consider joining the MDL if eligible.
Since the case moves towards its key “Science Day” by early 2026 and bellwether trials thereafter, the strength of scientific evidence and expert testimony will play a minor role in shaping the outcomes both for individuals and the potential for wide-scale settlement. The legal observers and advocacy groups, including PFL, are closely watching these developments. Staying updated could make a huge difference.
